Japan Veterinary Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Japan Veterinary Healthcare Market is segmented by Product (Therapeutics and Diagnostics), Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals)

Market Snapshot

Study Period:

2018 - 2026

Base Year:



6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The risk from zoonotic diseases is fueling the market for Japan veterinary healthcare. Inter-Governmental Organizations and food production are making reforms to ensure health by the process of surveillance and vaccination, investing in R&D, and transfer with respect to vet health. Additionally, advanced technology leading to innovations in animal healthcare, increase in ownership of pet animals and increasing awareness about the health of animals consumed as food are also the factors responsible for the growth of Japan veterinary healthcare market. In 2017, there were 8.92 million pet dogs and 9.52 pet cats in Japan, according to data from the Japan Pet Food Association. However, increasing costs of animal testing and veterinary services, lack of infrastructure and funding and use of counterfeit medicines are restraining the growth of Japan veterinary healthcare market.

Scope of the Report

As per the scope of this report, the Japan veterinary healthcare market is growing, comprising therapeutic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canine, feline, and equine. Farm animals are bovine, poultry, and porcine.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Molecular Diagnostics holds the major share in Japan Veterinary Healthcare Market

Molecular diagnostics refers to the class of tests performed on an animal, which can assess its health, literally, at the molecular level. It identifies the specific sequence in genes, DNA, RNA, and proteins. It also provides insights on whether the animal has a disease or will have a disease in the future, etc. In Japan, the academic activity in veterinary sciences is showing excellent response to molecular diagnostic methods. The department of veterinary medical sciences at the Graduate School of Agricultural & Life Sciences, University of Tokyo, is involved in conducting advanced molecular, cellular and in vivo levels, in order to fully understand vital processes of normal and diseased animals. Currently, in Japan, three nucleic-acid-based assays, viz., reverse transcription-polymerase chain reaction (RT-PCR), reverse transcription loop-mediated isothermal amplification (RT-LAMP), and real-time RT-PCR, have been developed for detection of Japanese encephalitis virus.

To understand key trends, Download Sample Report

Competitive Landscape

The market for Japan Veterinary Healthcare is majorly dominated by the few players. However, there are few companies that are penetrating the market currently and are expected to hold a substantial share in the market. Major players of the market are Zoetis Inc., Virbac, DS Pharma Animal Health Co., Carus Animal Health Ltd, Nisseiken Co., Ltd., Sumitomo Corporation, Bayer Holding Ltd, NIHON NOHYAKU CO., LTD., NIPPON ZENYAKU KOGYO CO., LTD. Unicharm Corporation amongst others

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

      1. 4.1.1 Advanced Technology Leading to Innovations in Animal Healthcare

      2. 4.1.2 Increasing Productivity at the Risk of Emerging Zoonosis

    2. 4.2 Market Restraints

      1. 4.2.1 Increasing Cost of Animal Testing and Veterinary Services

      2. 4.2.2 Use of Counterfeit Medicines

    3. 4.3 Porter's Five Force Analysis

      1. 4.3.1 Threat of New Entrants

      2. 4.3.2 Bargaining Power of Buyers/Consumers

      3. 4.3.3 Bargaining Power of Suppliers

      4. 4.3.4 Threat of Substitute Products

      5. 4.3.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. Vaccines

        2. Parasiticides

        3. Anti-infectives

        4. Medical Feed Additives

        5. Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. Immunodiagnostic Tests

        2. Molecular Diagnostics

        3. Diagnostic Imaging

        4. Clinical Chemistry

        5. Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals


    1. 6.1 Company Profiles

      1. 6.1.1 Zoetis Inc.

      2. 6.1.2 Virbac

      3. 6.1.3 DS Pharma Animal Health Co.

      4. 6.1.4 Carus Animal Health Ltd

      5. 6.1.5 Nisseiken Co., Ltd.

      6. 6.1.6 Sumitomo Corporation

      7. 6.1.7 Bayer Holding Ltd

      8. 6.1.8 NIHON NOHYAKU CO.,LTD.


      10. 6.1.10 Unicharm Corporation

  7. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports